Safety of pembrolizumab for resected stage III melanoma.

F Pham,S. Dalle

Safety of pembrolizumab for resected stage III melanoma.

2020

F Pham
S. Dalle

Patients with resected stage III melanoma have a heterogeneous prognosis with an especially high risk of relapse for patients with stage IIIB, IIIC and IIID according to the 2018 classification in ...

Keywords:

Medicine
Placebo
Internal medicine
Oncology
Cancer staging
Adjuvant
Adjuvant therapy
Nivolumab
Melanoma
Pembrolizumab
Ipilimumab

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations